These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 6823990)
1. Comprehensive pharmacy-based investigational drug service. Benfell K; Powell SH; Kaul AF Am J Hosp Pharm; 1983 Jan; 40(1):64-7. PubMed ID: 6823990 [No Abstract] [Full Text] [Related]
2. Providing investigational drug data through a hospitalwide computer system. Schwartz PA; Vogenberg FR Am J Hosp Pharm; 1983 Jan; 40(1):114-5. PubMed ID: 6337481 [No Abstract] [Full Text] [Related]
3. Innovative nuclear pharmacy service. A comprehensive management plan for clinical investigations. Cheng KT; Brown BM; Sheppard MS; Haymond DJ J Pharm Technol; 1993; 9(5):197-200. PubMed ID: 10130305 [TBL] [Abstract][Full Text] [Related]
4. Development and funding of a pharmacy-based investigational drug service. Ryan ML; Colvin CL; Tankanow RM Am J Hosp Pharm; 1987 May; 44(5):1069-74. PubMed ID: 3605116 [TBL] [Abstract][Full Text] [Related]
5. A survey of pharmacy-coordinated investigational drug services. Cipywnyk DM; McBride J Can J Hosp Pharm; 1991 Aug; 44(4):183-8, 200. PubMed ID: 10112895 [TBL] [Abstract][Full Text] [Related]
6. Coordinating investigational drug studies in the hospital. Zellmer WA Am J Hosp Pharm; 1982 Mar; 39(3):425. PubMed ID: 7072726 [No Abstract] [Full Text] [Related]
7. Fee structure for investigational drug studies. Anandan JV; Isopi MJ; Warren AJ Am J Hosp Pharm; 1993 Nov; 50(11):2339-43. PubMed ID: 8266958 [TBL] [Abstract][Full Text] [Related]
8. Pharmacy-coordinated investigational drug services. Stolar MH; Gabriel T; Grant KL; Koeller J; Letendre DE Am J Hosp Pharm; 1982 Mar; 39(3):232-6. PubMed ID: 7072723 [TBL] [Abstract][Full Text] [Related]
10. Linking a policy on nonformulary drugs to the FDA's therapeutic-potential classification system. Poirier TI; Vorbach M; Bache T Am J Hosp Pharm; 1994 Sep; 51(18):2277-8. PubMed ID: 7801989 [No Abstract] [Full Text] [Related]
11. ASHP guidelines for the use of investigational drugs in institutions. Am J Hosp Pharm; 1983 Mar; 40(3):449-51. PubMed ID: 6846357 [No Abstract] [Full Text] [Related]
12. Procedures for emergency or treatment use of investigational drugs. Klecker RJ; Cipolle RJ Am J Hosp Pharm; 1987 May; 44(5):1086-9. PubMed ID: 3605118 [TBL] [Abstract][Full Text] [Related]
13. An evaluation of the education of hospital pharmacy directors. Oakley RS; Bradham DD; Kimberlin CL Am J Pharm Educ; 1985; 49(3):277-81. PubMed ID: 10274928 [TBL] [Abstract][Full Text] [Related]
14. Managing the hospital pharmacy. Interview by Nancy M. Agresta. Lantos RL Hosp Formul; 1979 Sep; 14(9):839-43. PubMed ID: 10243910 [No Abstract] [Full Text] [Related]
16. How we comply with federal guidelines on THC dispensing. Goldstein MS; Williams FF Pharm Times; 1981 Oct; 47(10):32-6. PubMed ID: 10278105 [No Abstract] [Full Text] [Related]
17. Justification and evaluation of an aminoglycoside pharmacokinetic dosing service. Jorgenson JA; Rewers RF Hosp Pharm; 1991 Jul; 26(7):605, 609-11, 615. PubMed ID: 10111793 [TBL] [Abstract][Full Text] [Related]
18. The history of a comprehensive pharmacokinetic service. McLean W; Lalonde R; Roy M Can J Hosp Pharm; 1989 Dec; 42(6):223-8. PubMed ID: 10304198 [TBL] [Abstract][Full Text] [Related]
19. Hospitals vigilant for quality in pharmacy. Perry PA Hosp Mater Manage; 1989 Dec; 14(12):1-2. PubMed ID: 10296163 [No Abstract] [Full Text] [Related]
20. Pharmacy continuing education--its value to hospital pharmacy practice. Oakley RS; Lemberger MA Am J Pharm Educ; 1985; 49(1):58-61. PubMed ID: 10272590 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]